Cargando…
Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors
Cancer stem cell (CSC) has become recognized for its role in both tumorigenesis and poor patient prognosis in recent years. Traditional therapeutics are unable to effectively eliminate this group of cells from the bulk population of cancer cells, allowing CSCs to persist posttreatment and thus propa...
Autores principales: | Mladinich, Megan, Ruan, Diane, Chan, Chia-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093281/ https://www.ncbi.nlm.nih.gov/pubmed/27840647 http://dx.doi.org/10.1155/2016/5285892 |
Ejemplares similares
-
Melatonin Inhibits EMT in Bladder Cancer by Targeting Autophagy
por: Hsiao, Sheng-Yen, et al.
Publicado: (2022) -
Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy
por: He, Jiabei, et al.
Publicado: (2019) -
Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021) -
EMT or EMT-Promoting Transcription Factors, Where to Focus the Light?
por: Ansieau, Stéphane, et al.
Publicado: (2014) -
ZIKV induction of tristetraprolin in endothelial and Sertoli cells post-transcriptionally inhibits IFNβ/λ expression and promotes ZIKV persistence
por: Schutt, William R., et al.
Publicado: (2023)